Asset Details
Do you wish to reserve the book?
Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study
Do you wish to request the book?
Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study
2021
Overview
Observational studies suggest alcohol use promotes the development of some adverse cardiometabolic traits but protects against others including outcomes related to coronary artery disease. We used Mendelian randomization (MR) to explore causal relationships between the degree of alcohol consumption and several cardiometabolic traits in the UK Biobank. Using the well-established ADH1B Arg47His variant (rs1229984) and up to 24 additional SNPs recently found to be associated with alcohol consumption in an independent dataset as instruments, we conducted two-stage least squares and inverse weighted variance MR analyses, both as one-sample analyses in the UK Biobank and as two-sample analyses in external consortia. In the UK Biobank inverse variance weighted analyses, we found that one additional drink of alcohol per day was positively associated with systolic blood pressure (beta = 2.65 mmHg [1.40, 3.89]), hemorrhagic stroke (OR = 2.25 [1.41, 3.60]), and atrial fibrillation (OR = 1.26 [1.07, 1.48]), which were replicated in multivariable analyses. Alcohol was also associated with all cardiovascular disease and all-cause death. A positive association with myocardial infarction did not replicate in multivariable analysis, with suggestive mediation through blood pressure; similarly, a positive association between alcohol use with type 2 diabetes was mitigated by BMI in multivariable analysis. Findings were generally null in replication with two-sample analyses. Alcohol was not protective for any disease outcome with any analysis method, dataset, or strata. Stratifications by sex and smoking in the UK Biobank revealed higher point estimates of risk for several outcomes for men and mixed results for smoking strata, but no statistically significant heterogeneity. Our results are consistent with an overall harmful and/or null effect of alcohol on cardiometabolic health at all levels of use and suggest that even moderate alcohol use should not be promoted as a part of a healthy diet and lifestyle.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Aged
/ Alcohol Dehydrogenase - genetics
/ Alcohol Drinking - adverse effects
/ Alcohols
/ Atrial Fibrillation - etiology
/ Biobanks
/ Cardiovascular Diseases - etiology
/ Cardiovascular Diseases - pathology
/ Datasets
/ Diabetes
/ Diabetes mellitus (non-insulin dependent)
/ Diabetes Mellitus, Type 2 - pathology
/ Drinking of alcoholic beverages
/ Female
/ Funding
/ Hemorrhagic Stroke - etiology
/ Humans
/ Lipids
/ Male
/ Medicine
/ Medicine and Health Sciences
/ Mendelian Randomization Analysis
/ Polymorphism, Single Nucleotide
/ Single-nucleotide polymorphism
/ Smoking
/ Strata
/ Stroke
Seems like something went wrong :( Kindly try again later!